$AOYUAN HEALTHY(03662)$Another positive profit alert for the interim results due mid Aug 21. Not less than 50% increase YOY in net profit. EPS should increase from $0.41 to $0.60. Forward PE @ $5.18 would be 8.6 which is dirt cheap for a PM company that is delivering results. Overweight and Buy. Target = $9

$AOYUAN HEALTHY(03662)$With the newly revised annual caps, it means there is an agreement with China Aoyuan to raise the minimum revenue caps for Aoyuan Healthy. It is a promising sign that the actual revenue for FY2021-23 may see a revision upwards. Using FY2020 as a historical example- the FY2020 revised cap was published at 705000000 RMB and the actual came in at 1408089000 RMB, about double. Here are FY2021-23 revised annual caps and you can make a good estimate of what the future revenue would be :FY2020 - 705000000 RMB FY2021 - 1036620000 RMB (+47% YOY)FY2022 - 1381890000 RMB (+33.3%)FY2023 - 1842900000 RMB (+33.3%)The revenue growth for FY2021 can be estimated to be 47%. With FY2020 EPS of $0.41, the es

$JD HEALTH(06618)$Valued so much higher than Ali Health now. JD Health is not even making a profit.... Ali Health is. I think Ali Health is undervalued relatively. 

$CHINA RES MIXC(01209)$At this price $31, the PE based on annualised 1H20 results, is 85. Way too high! PE 60 is reasonable. Will fall sharply once the heat is over. Be cautious. 

$CHINA SCE GROUP(01966)$With the impending spin-off and listing of the highly profitable CM business, there is a great opportunity to profit from this spin-off. There is 1 reserved CM share for every 33 China SCE shares but I would not buy into China SCE now to enjoy the entitlement or to apply for IPO allocation of CM shares. My recommendation is to let the CM shares to be floated and traded for a few weeks and then buy in when there is a sharp correction. Valuation of PM or CM at IPO is way too high right now. Be patient and wait. 

$LANGUANGJUSTBON(02606)$An offer price not less than HK$50.58 from CG Services to takeover all shares owned by the main shareholder of LabguangJustbon - 30% higher than the closing price of $38.95 before the suspension of trading. Not accepted yet, still under negotiation and suspension of trading is still active. It basically shows that many of these smaller profitable PM companies are heavily undervalued like Aoyuan Healthy01996. I personally think that the offer price is way too low - current PE of LanguangJustbon is about 11 - paying 30% more is not much more. Should be valued at PE of 30 or higher. That could be why CG Services is seeing higher value in them and could help to increase its share value with CG’s help.https://www1.h

$KWG LIVING(03913)$70% increase in 2020 earnings over 2019. It would mean a 2020 PE of 29. at IPO price of $7.89. $8.16 now would make a PE of 30. Further upside opportunity with 2021 earnings expected to grow again. Buy when there is a correction.